Nadler J - Search Results

1

Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.

Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ. Phillips JW, et al. Among authors: nadler j. Circulation. 2003 Oct 21;108(16):1994-9. doi: 10.1161/01.CIR.0000092886.52404.50. Epub 2003 Sep 29. Circulation. 2003. PMID: 14517165

2

Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.

Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, Srinivasan S, Hedrick CC, Praticò D, Witztum JL, Nadler JL, Funk CD, Ley K. Huo Y, et al. Circulation. 2004 Oct 5;110(14):2024-31. doi: 10.1161/01.CIR.0000143628.37680.F6. Epub 2004 Sep 27. Circulation. 2004. PMID: 15451785

3

Lisofylline: a potential lead for the treatment of diabetes.

Yang Z, Chen M, Nadler JL. Yang Z, et al. Biochem Pharmacol. 2005 Jan 1;69(1):1-5. doi: 10.1016/j.bcp.2004.08.012. Biochem Pharmacol. 2005. PMID: 15588708 Review.

4

Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.

Yang Z, Chen M, Carter JD, Nunemaker CS, Garmey JC, Kimble SD, Nadler JL. Yang Z, et al. Biochem Biophys Res Commun. 2006 Jun 9;344(3):1017-22. doi: 10.1016/j.bbrc.2006.03.177. Epub 2006 Apr 5. Biochem Biophys Res Commun. 2006. PMID: 16643856

5

12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.

Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD, Yang Z, Smith KM, Wu R, Bevard MH, Garmey JC, Nadler JL. Nunemaker CS, et al. Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1065-75. doi: 10.1152/ajpendo.90371.2008. Epub 2008 Sep 9. Am J Physiol Endocrinol Metab. 2008. PMID: 18780776 Free PMC article.

6

Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.

Galkina EV, Butcher M, Keller SR, Goff M, Bruce A, Pei H, Sarembock IJ, Sanders JM, Nagelin MH, Srinivasan S, Kulkarni RN, Hedrick CC, Lattanzio FA, Dobrian AD, Nadler JL, Ley K. Galkina EV, et al. Among authors: nadler jl. Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):247-56. doi: 10.1161/ATVBAHA.111.240358. Epub 2011 Dec 22. Arterioscler Thromb Vasc Biol. 2012. PMID: 22199371 Free PMC article.

7

Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism.

Chen M, Yang Z, Wu R, Nadler JL. Chen M, et al. Endocrinology. 2002 Jun;143(6):2341-8. doi: 10.1210/endo.143.6.8841. Endocrinology. 2002. PMID: 12021199

8

The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.

Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. Yang Z, et al. Pancreas. 2003 May;26(4):e99-104. doi: 10.1097/00006676-200305000-00021. Pancreas. 2003. PMID: 12717280

9

The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.

Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Brinkmann V, Nadler JL, Lynch KR. Yang Z, et al. Clin Immunol. 2003 Apr;107(1):30-5. doi: 10.1016/s1521-6616(02)00054-2. Clin Immunol. 2003. PMID: 12738247

10

The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.

Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, Nadler JL. Yang Z, et al. Transplantation. 2004 Jan 15;77(1):55-60. doi: 10.1097/01.TP.0000104844.48064.81. Transplantation. 2004. PMID: 14724435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters